Sg Capital Management buys $18,192,554 stake in Natus Medical Inc (BABY)

Natus Medical Inc (BABY) : Sg Capital Management scooped up 220,097 additional shares in Natus Medical Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 468,518 shares of Natus Medical Inc which is valued at $18,192,554.Natus Medical Inc makes up approximately 4.04% of Sg Capital Management’s portfolio.

Other Hedge Funds, Including , Municipal Employees’ Retirement System Of Michigan boosted its stake in BABY in the latest quarter, The investment management firm added 180 additional shares and now holds a total of 8,890 shares of Natus Medical Inc which is valued at $345,199. Natus Medical Inc makes up approx 0.02% of Municipal Employees’ Retirement System Of Michigan’s portfolio.Argentus Capital Management reduced its stake in BABY by selling 2,236 shares or 29.37% in the most recent quarter. The Hedge Fund company now holds 5,376 shares of BABY which is valued at $208,750. Natus Medical Inc makes up approx 0.09% of Argentus Capital Management’s portfolio.Clinton Group Inc boosted its stake in BABY in the latest quarter, The investment management firm added 64 additional shares and now holds a total of 8,614 shares of Natus Medical Inc which is valued at $334,482. Natus Medical Inc makes up approx 0.01% of Clinton Group Inc’s portfolio.Great West Life Assurance Co Can boosted its stake in BABY in the latest quarter, The investment management firm added 39,997 additional shares and now holds a total of 43,742 shares of Natus Medical Inc which is valued at $1,679,693. Simplex Trading sold out all of its stake in BABY during the most recent quarter. The investment firm sold 2,392 shares of BABY which is valued $94,412.

Natus Medical Inc opened for trading at $38.91 and hit $40.37 on the upside on Thursday, eventually ending the session at $39.71, with a gain of 2.06% or 0.8 points. The heightened volatility saw the trading volume jump to 3,61,521 shares. Company has a market cap of $1,308 M.

On the company’s financial health, Natus Medical Inc reported $0.39 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 20, 2016. Analyst had a consensus of $0.36. The company had revenue of $96.00 million for the quarter, compared to analysts expectations of $92.71 million. The company’s revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.34 EPS.

Natus Medical Incorporated (Natus) is a provider of newborn care and neurology healthcare products and services used for the screening diagnosis detection treatment monitoring and tracking of common medical ailments in newborn care hearing impairment neurological dysfunction epilepsy sleep disorders and balance and mobility disorders. The Company offers two product families: Neurology which includes products and services for diagnostic electroencephalography and long term monitoring intensive care unit monitoring electromyography sleep analysis intra-operative monitoring and diagnostic and monitoring transcranial doppler ultrasound technology; and Newborn Care which includes products and services for newborn care including hearing screening brain injury thermoregulation jaundice management and various disposable products as well as products for diagnostic hearing assessment for children through adult populations and others.

Leave a Reply

Natus Medical Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Natus Medical Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.